NFKB1 and Sepsis: found that using selective beta-blockers (especially atenolol) improved sepsis incidence and course, significantly reduced serum sPD-L1 levels, and facilitated ROS-induced NF-κB and STAT3 activation, thus down-regulating PD-L1 expression on monocytes/macrophages (205).